Founded in 2021, Neuranics operates in Enterprise Tech industry. Initially, the company concentrated on developing advanced diagnostic solutions to enhance accuracy and speed in healthcare assessments...
Funding stage:
Seed
Last funding:
04/12/2024
Total funding:
$700.00K+
Revenue:
Investors
Employee count:
19
Last 90d
19
Last 90d
Web traffic:
1.15K
1.15K
Last 30d
Last 30d
Neuranics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders35
Latest Filing Date14 Oct 2025- Funding Events16
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Neuranics
As of 15 October 2025, Neuranics's equity is held by 33 shareholders, with the top three being Ashutosh Patra, Praveen Kumar, and Samanviidaas.
Ashutosh Patra holds the largest stake in Neuranics at 38.7% as of 15 October 2025.
As of 15 October 2025, founders collectively hold 77.3% equity in Neuranics.
As of 15 October 2025, investors collectively hold 14.2% equity in Neuranics.
Neuranics's ESOP pool stands at 5.3% of total equity as of 15 October 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links